Nuvectis Pharma, Inc. (NVCT)

NCM – Цена в реальном времени. Валюта: USD

19.54

+0.13 (0.67%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

19.54

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:00 PM EDT

04.08.2026

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

FORT LEE, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today reported its financial results for the second quarter of 2026 and provided an update on recent business progress.

Видео

No Data

There is no data to display

Пресс-релизы

04.08.2026

Nuvectis Pharma, Inc. (NVCT)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Видео

No Data

Пресс-релизы

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Видео

No Data

Пресс-релизы

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Search stocks

Nuvectis Pharma, Inc. (NVCT)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Видео

No Data

Пресс-релизы

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Видео

No Data

Пресс-релизы

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights